Cold agglutinins are predominately immunoglobulin M autoantibodies that react at cold temperatures with surface antigens on the red blood cell. This can lead to hemagglutination at low temperatures, followed by complement fixation and subsequent hemolysis on rewarming. Development of hemagglutination or hemolysis in patients with cold agglutinins is a risk of cardiac surgery under hypothermia. In addition, there is the potential for intracoronary hemagglutination with inadequate distribution of cardioplegic solutions, thrombosis, embolism, ischemia, or infarction. We report a patient with incidentally detected cold agglutinin who underwent normothermic cardiac surgery with warm blood cardioplegia. 
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DISCUSSION
Cold agglutinin disease (cold antibody disease) is caused by autoantibodies that react at decreased blood temperature and produce agglutination or hemolysis of red blood cells [1] [2] [3] . The causes of this situation include infections (especially mycoplasmal pneumonias or infectious mononucleosis), lymphoproliferative disorders, and idiopathic diseases (about half ofcases). Infections tend to cause acute disease, whereas idiopathic disease (the common form in older adults) tends to be chronic [1] . The most clinically relevant characteristic of cold agglutinins is thermal amplitude, the temperature below which the antibodies become activated (Fig. 1) . During surgery, the heart was arrested using a 4°C blood cardioplegia solution, and agglutinated blood was found when the coronary artery was incised [2] .
Treatment for patients with cold agglutinins during cardiac To conclude, we report a patient with incidentally detected cold agglutinins with a relatively high titer who underwent normothermic cardiac surgery with warm blood cardioplegia.
Cold agglutinemia in patients requiring cardiac procedures using CPB can cause severe complications due to hemagglutination and hemolysis. In these patients, the use of warm blood cardioplegia combined with normothermic extracorporeal circulation may have a successful outcome without complications of cold agglutinin after cardiac surgery.
